Gevo Wins Appeals Court Ruling in Butamax Patent Dispute

Butamax Advanced Biofuels LLC, a joint venture of DuPont Co. and BP Plc (BP/), lost an appeals court bid to block Gevo Inc. (GEVO) from selling some of its biofuels products while a patent-infringement case is pending.

Gevo has raised “a substantial question of validity” of the Butamax patent, the U.S. Court of Appeals for the Federal Circuit said in upholding a judge’s decision not to issue a court ban. The court did say that U.S. District Judge Sue Robinson in Wilmington, Delaware should reconsider her interpretation of the patent. The case is part of a broader dispute between the two companies over genetically engineered microorganisms used to produce biofuels.

To contact the reporter on this story: Susan Decker in Washington at sdecker1@bloomberg.net

To contact the editor responsible for this story: Bob Drummond at bdrummond@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.